| Previous Section | Index | Home Page |
22 Feb 2010 : Column 114W—continued
Cancer: Drugs
Michael Connarty: To ask the Secretary of State for Health what assessment his Department has made of the merits of providing to patients with rare cancers second line treatments licensed for their conditions. [316548]
Ann Keen: The Department has made no assessment of the merits of providing to patients with rare cancer second line treatments licensed for their conditions.
However, second line treatments for patients with rarer cancers are included in the National Institute for Health and Clinical Excellence's programme of work on cancer. Full details of completed and ongoing appraisals of these treatments can be found at
Michael Connarty: To ask the Secretary of State for Health (1) what steps he plans to take to reduce the time taken for individual funding requests for drug treatment from patients with metastatic cancer to be processed; [317381]
(2) what assessment he has made of the performance of each primary care trust in meeting the timescales set out in the National Prescribing Centre's guidance on Principles for Processes Supporting Local Decision-making about Medicines in (a) decision making, (b) communication of outcome, (c) case type and (d) appeals processes. [317382]
Mr. Mike O'Brien: The National Prescribing Centre's document, 'Defining Guiding Principles for Processes supporting Local Decision Making about Medicines', available at:
makes it clear that primary care trusts (PCTs) should make decisions in a reasonable and practical timeframe, but without compromising the minimum process requirements, even when requests are urgent. We expect PCTs to exercise their judgment when setting timeframes for dealing with individual requests. We have not made an assessment of PCT performance in dealing with such requests.
Cancer: Hemsworth
Jon Trickett: To ask the Secretary of State for Health how many and what percentage of suspected cancer patients resident in Hemsworth saw an NHS consultant within two weeks of referral in each year since 1997. [316629]
Ann Keen: The information is not available in the format requested. The following table shows the number of people seen and the percentage seen within two weeks, following urgent referral with suspected cancer for Barnsley Hospital NHS Foundation Trust and Mid- Yorkshire Hospitals NHS Trust.
Cancer: Kidneys
Michael Connarty: To ask the Secretary of State for Health what the incidence of kidney cancer was in each region in each of the last five years. [317509]
Angela E. Smith: I have been asked to reply.
The information requested falls within the responsibility of the UK Statistics Authority. I have asked the authority to reply.
Letter from Stephen Penneck, dated February 2010:
As Director General for the Office for National Statistics, I have been asked to reply to your recent Parliamentary Question asking what the incidence of kidney cancer was in each region in each of the last five years. [317509]
The latest available figures for newly diagnosed cases of kidney cancer (incidence) are for the year 2007. Please note that these numbers may not be the same as the number of people diagnosed with cancer, because one person may be diagnosed with more than one cancer.
Table 1 provides the numbers of newly diagnosed cases of kidney cancer in each government office region in England, for each year from 2003 to 2007.
| Table 1. Registrations of newly diagnosed cases of kidney cancer,( 1) government office regions, England,( 2) 2003 to 2007( 3) | |||||
| Persons | |||||
| 2003 | 2004 | 2005 | 2006 | 2007 | |
| (1) Kidney cancer is coded as C64 in the International Classification of Diseases, Tenth Revision (ICD-10). (2) Based on boundaries as of 2009. (3) Newly diagnosed cases registered in each calendar year. | |||||
| Next Section | Index | Home Page |